Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

Primary Cutaneous T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

328 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 30
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (73)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00699296	Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma	terminated	Phase 2	4	Novartis PharmaceuticalsINDUSTRY	1	Nov 27, 2012	clinicaltrials
NCT00127881	Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome	terminated	Phase 3	76	Emergent Product Development Seattle LLCINDUSTRY	5	Jul 26, 2012	clinicaltrials